A new strategy to follow up head and neck cancer (HNC) patients at 1 year from end of treatment has been developed. This follow-up is guided by a PET-CT scan to determine the risk of cancer coming back (called recurrence) and allows low risk HNC patients to have patient-led follow-up, giving them more control over their follow-up appointments.